Table 2.
Main outcomes by intervention groups.
| A. Main outcomes by intervention group | ||||
|---|---|---|---|---|
| Outcomes | Regimen started | |||
| BAM/ETE | CAS/IMD | p-value* | Total | |
| N= 237 | N= 196 | N= 433 | ||
| Primary Outcome a , n(%) | 15 (6.3%) | 4 (2.0%) | 0.030 | 19 (4.4%) |
| 1st Secondary Outcome b , n(%) | 21 (8.9%) | 8 (4.1%) | 0.048 | 29 (6.7%) |
| 2nd Secondary Outcome c , n(%) | 9 (3.8%) | 2 (1.0%) | 0.068 | 11 (2.5%) |
BAM/ETE, bamlanivimab/etesevimab; CAS/IMD, casirivimab/imdevimab.
a
Patients with COVID-19 related hospitalization or death for any cause over days 0-30.
b
Patients with hospitalization or death for any cause over days 0-30.
c
Patients with hospitalization or death for any cause over days 3-30.
*Chi-square.